Feeding during therapeutic hypothermia is safe and may improve outcomes in newborns with perinatal asphyxia.


Journal

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians
ISSN: 1476-4954
Titre abrégé: J Matern Fetal Neonatal Med
Pays: England
ID NLM: 101136916

Informations de publication

Date de publication:
Dec 2022
Historique:
pubmed: 16 2 2022
medline: 24 11 2022
entrez: 15 2 2022
Statut: ppublish

Résumé

We assessed the impact of early enteral feeding introduction during therapeutic hypothermia on time to reach full enteral feeding (FEF) and other feeding related outcomes in infants born at ≥35 weeks gestational age and diagnosed with moderate to severe Hypoxic-Ischemic Encephalopathy. A prospective cohort with historical control study, conducted on infants admitted to the Alberta Children's Hospital level III NICU in Calgary between January 2013 and December 2018. Infants were divided into 2 groups: (1) unfed group (UG), which was kept nil per os during the 72 h of therapeutic Hypothermia (TH), with subsequent introduction of feeding and gradual increase to FEF; (2) fed group (FG), which received feeding at 10 mL/kg/day during TH then increased gradually to FEF. Groups were compared for time to FEF and the type of milk they were being fed on discharge. Other gut related health risks such as NEC and sepsis were examined. During the study period, 146 infants received therapeutic hypothermia, of whom 75 in the UG and 71 in the FG. The FG compared to the UG received the first feed sooner after TH initiation (median 57 vs. 86.5 h, Minimal enteral feeding during therapeutic hypothermia appears to be safe and leads to a shorter time to FEF and higher rates of breast milk feeding at discharge.

Identifiants

pubmed: 35164630
doi: 10.1080/14767058.2022.2041594
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

9440-9444

Auteurs

Wissam Alburaki (W)

Dalhousie and Memorial Universities, New Brunswick, Canada.

Maxine Scringer-Wilkes (M)

Alberta Health Services, Alberta Children Hospital, Calgary, Canada.

Fady Dawoud (F)

Alberta Health Services, Alberta Children Hospital, Calgary, Canada.

Norma Oliver (N)

Alberta Health Services, Alberta Children Hospital, Calgary, Canada.

Janice Lind (J)

Alberta Health Services, Alberta Children Hospital, Calgary, Canada.

Hussein Zein (H)

Alberta Health Services, Alberta Children Hospital, Calgary, Canada.
Department of Pediatrics, Section of Neonatology, University of Calgary, Calgary, Canada.

Lara M Leijser (LM)

Alberta Health Services, Alberta Children Hospital, Calgary, Canada.
Department of Pediatrics, Section of Neonatology, University of Calgary, Calgary, Canada.

Michael J Esser (MJ)

Alberta Health Services, Alberta Children Hospital, Calgary, Canada.
Department of Pediatrics, Sections of Pediatric Neurology, University of Calgary, Calgary, Canada.

Khorshid Mohammad (K)

Alberta Health Services, Alberta Children Hospital, Calgary, Canada.
Department of Pediatrics, Section of Neonatology, University of Calgary, Calgary, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH